Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Amprion

Amprion

A leader in Prion Detection Science™, Amprion innovates biomarker testing for brain diseases. Our SYNTap® Biomarker Test helps doctors diagnose Lewy Body Variant of Alzheimer's Disease, Parkinson's Disease, and Lewy Body Dementia. Awarded FDA Breakthrough Device Designation for its detection technology, Amprion strives to accelerate precision medicine for neurodegenerative diseases through molecular testing.

Last updated on

About Amprion

Founded

2007

Estimated Revenue

$1M-$10M

Employees

11-50

Funding / Mkt. Cap

$11M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Location

City

Houston

State

Texas

Country

United States

Tech Stack (28)

search